Colorectal
Mount Carmel is taking the lead in the prevention and treatment of colorectal cancer - the second-leading cause of cancer-related deaths in the United States for both men and women.

The good news is that some colorectal cancers are preventable. When detected early, colorectal cancer has a high cure rate. That's why Mount Carmel emphasizes the prevention and early detection of colorectal cancer. Through regular screenings, small growths in the colon can be removed before they become cancerous.

For those diagnosed with colorectal cancer, Mount Carmel offers advanced treatment not only to eliminate the disease but also to preserve patients' ability to function normally. Our surgeons, oncologists and radiologists use techniques that help to preserve bladder, bowel and sexual function. Patients with colorectal cancer who might have required a permanent colostomy are now offered other alternatives.

Mount Carmel is actively involved in clinical research, offering a variety of cancer treatment protocols for colorectal patients. Mount Carmel is an active participant in a number of other FDA- and NCI-sponsored clinical trials involving the efficacy of a variety of chemotherapy and radiation regimens in colorectal patients.